Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia
Marisa R. Morrow, Battsetseg Batchuluun, Jianhan Wu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 919-936.e8
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Acetyl-CoA metabolism in cancer
David A. Guertin, Kathryn E. Wellen
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 156-172
Open Access | Times Cited: 136
GDF15 promotes weight loss by enhancing energy expenditure in muscle
Dongdong Wang, Logan K. Townsend, Geneviève J. DesOrmeaux, et al.
Nature (2023) Vol. 619, Iss. 7968, pp. 143-150
Open Access | Times Cited: 118
NAFLD and NASH: etiology, targets and emerging therapies
Shulin Wei, Li Wang, Paul C. Evans, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103910-103910
Closed Access | Times Cited: 59
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 57
Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis
Luke Izzo, Sophie Trefely, Christina Demetriadou, et al.
Science Advances (2023) Vol. 9, Iss. 18
Open Access | Times Cited: 56
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 35
Bempedoic Acid: for Whom and When
Massimiliano Ruscica, Cesare R. Sirtori, Stefano Carugo, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 10, pp. 791-801
Open Access | Times Cited: 51
The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK
Chen‐Song Zhang, Mengqi Li, Yu Wang, et al.
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1369-1401
Open Access | Times Cited: 47
Branched-Chain Amino Acids and Insulin Resistance, from Protein Supply to Diet-Induced Obesity
Jean‐Pascal De Bandt, Xavier Coumoul, Robert Barouki
Nutrients (2022) Vol. 15, Iss. 1, pp. 68-68
Open Access | Times Cited: 43
Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
Gianni Biolo, Pierandrea Vinci, Alessandro Mangogna, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 41
AMPK and the Endocrine Control of Metabolism
Logan K. Townsend, Gregory R. Steinberg
Endocrine Reviews (2023) Vol. 44, Iss. 5, pp. 910-933
Closed Access | Times Cited: 37
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Emanuel Raschi, Manuela Casula, Arrigo F.G. Cicero, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108507-108507
Open Access | Times Cited: 34
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Inês Domingues, Isabelle Leclercq, Ana Beloqui
Journal of Controlled Release (2023) Vol. 363, pp. 415-434
Closed Access | Times Cited: 28
Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
Tingting Zhou, Ligang Cao, Yimei Du, et al.
PeerJ (2023) Vol. 11, pp. e15225-e15225
Open Access | Times Cited: 23
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Targeting Grancalcin Accelerates Wound Healing by Improving Angiogenesis in Diabetes
Peng Xiang, Meng Jiang, Xin Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 12
Glucose controls lipolysis through Golgi PtdIns4P-mediated regulation of ATGL
Lianggong Ding, Florian Huwyler, Fen Long, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 4, pp. 552-566
Open Access | Times Cited: 12
Insulin at the intersection of thermoregulation and glucose homeostasis
Nathan C. Winn, Michael W. Schleh, Jamie N. Garcia, et al.
Molecular Metabolism (2024) Vol. 81, pp. 101901-101901
Open Access | Times Cited: 9
A genetically encoded fluorescent biosensor for visualization of acetyl-CoA in live cells
Joseph J. Smith, Taylor R. Valentino, Austin H. Ablicki, et al.
Cell chemical biology (2025)
Closed Access | Times Cited: 1
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Alexandra C Finney, Sandeep R. Das, Dhananjay Kumar, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
Paolo Convertini, Anna Santarsiero, Simona Todisco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones
Adam J. Rauckhorst, Ryan D. Sheldon, Daniel J. Pape, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 8
Regulation mechanism of endoplasmic reticulum stress on metabolic enzymes in liver diseases
Shaojun Zhou, Kaiwen Cheng, Yi‐Jen Peng, et al.
Pharmacological Research (2024) Vol. 207, pp. 107332-107332
Open Access | Times Cited: 7
Major specialized natural products from the endangered plant Heptacodium miconioides, potential medicinal uses and insights into its longstanding unresolved systematic classification
Ze‐Yu Zhao, Jiang Wan, Hao‐Wei Chen, et al.
Phytochemistry (2024) Vol. 228, pp. 114259-114259
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top